QTTB
Q32 Bio·NASDAQ
--
--(--)
--
--(--)
QTTB fundamentals
Q32 Bio (QTTB) released its earnings on Aug 6, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.78 (YoY +45.07%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.78
+45.07%
Report date
Aug 6, 2025
Earnings Call
4:00 PM on Aug 6, 2025
Meeting link.EPS
Actual | -14.04 | -14.04 | -11.16 | -11.16 | -0.36 | -9.72 | -9.72 | -9.18 | -10.62 | -10.8 | -9 | -10.98 | -10.26 | -3.31 | -6.33 | -1.42 | -1.46 | -1.16 | -0.9 | -0.78 | ||||||||
Forecast | -12.42 | -13.32 | -14.5575 | -11.8575 | -11.0475 | -10.35 | -10.566 | -9.676 | -8.2145 | -8.8601 | -9.54 | -8.505 | -7.56 | -5.4 | -1.415 | -0.9967 | -1.379 | -1.5304 | -1.23 | -0.9783 | ||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -13.04% | -5.41% | +23.34% | +5.88% | +96.74% | +6.09% | +8.01% | +5.13% | -29.28% | -21.89% | +5.66% | -29.10% | -35.71% | +38.70% | -347.35% | -42.47% | -5.87% | +24.20% | +26.83% | +20.27% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | 588.00K | 567.00K | 567.00K | 980.00K | 29.30M | 2.19M | 1.68M | 802.00K | 802.00K | 802.00K | 802.00K | 354.00K | -- | -14.66M | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | 580.00K | 491.14K | 573.00K | 1.22M | 576.86K | 429.70K | 643.70K | 1.00M | 860.60K | 830.60K | 1.01M | 830.50K | 500.00K | 500.00K | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +1.38% | +15.44% | -1.05% | -19.77% | +4980.12% | +408.96% | +160.53% | -19.88% | -6.81% | -3.44% | -20.95% | -57.38% | 0.00% | -3032.40% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What factors drove the changes in Q32 Bio's revenue and profit?What is Q32 Bio's latest dividend and current dividend yield?What guidance did Q32 Bio's management provide for the next earnings period?What is Q32 Bio's gross profit margin?Did Q32 Bio beat or miss consensus estimates last quarter?What were the key takeaways from Q32 Bio's earnings call?What does Q32 Bio do and what are its main business segments?What were the key takeaways from Q32 Bio’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
